Raymond James & Associates’s Xperi XPER Stock Holding History

Raymond James & Associates’s Portfolio XPER Stock Details XPER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$567K	Buy	61,392 +1,391	+2%	+$11.4K	﹤0.01%	3035
2024 Q2	$493K	Buy	60,001 +4,478	+8%	+$42.3K	﹤0.01%	3084
2024 Q1	$670K	Buy	55,523 +9,257	+20%	+$102K	﹤0.01%	2877
2023 Q4	$510K	Buy	46,266 +4,713	+11%	+$45.4K	﹤0.01%	2949
2023 Q3	$410K	Buy	41,553 +3,991	+11%	+$47.2K	﹤0.01%	3006
2023 Q2	$494K	Buy	37,562 +2,709	+8%	+$29.4K	﹤0.01%	2947
2023 Q1	$381K	Buy	34,853 +9,529	+38%	+$99.3K	﹤0.01%	3084
2022 Q4	$218K	Buy	+25,324	New	+$290K	﹤0.01%	3406

Other funds holding XPER

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Raymond James & Associates's XPER Position: Q3 2024 in Review

Raymond James & Associates increased its Xperi (XPER) stake by 2.3% in Q3 2024, buying an estimated $11.4K and bringing the position to 61,392 shares worth $567K. The position accounts for ﹤0.01% of the portfolio, ranked #3035.

Raymond James & Associates first reported a position in XPER in Q4 2022 and has held it in 8 quarters since. The position peaked at $670K in Q1 2024. 145 funds tracked by Wall St. Rank hold XPER as of Q3 2024.

Raymond James & Associates held 61,392 shares of Xperi worth $567K as of Q3 2024.
Raymond James & Associates bought 1,391 Xperi shares in Q3 2024, an estimated $11.4K.
Xperi made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3035 holding.
Raymond James & Associates first reported a position in Xperi in Q4 2022 and has held it in 8 quarters since.
Raymond James & Associates's Xperi position peaked at $670K in Q1 2024.
145 funds tracked by Wall St. Rank held Xperi as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.